Lee Siu Fong
Ms. Lee Siu Fong joined the Group in April 1997 and has since been responsible for the Group’s financial affairs. She is an entrepreneur and had since 1992 established and run several companies with primary responsibility in financial affairs. She is the sister of Ms. Leelalertsuphakun Wanee and Dr. Li Xiaoyi.
Managing Director, Chief Marketing & Sales Officer & member of remuneration committee
Ms. Leelalertsuphakun Wanee joined the Group in April 1997. She was appointed the Chief Marketing & Sales Officer in September 2003 and has been responsible for the Group’s sales and marketing activities since then. She is the sister of Ms. Lee Siu Fong and Dr. Li Xiaoyi.
Chief Executive Officer & Chief Technical Officer, PhD
Dr. Li Xiaoyi holds a PhD in Pharmacology from the University of Illinois at Chicago and was a postdoctoral fellow with Parke-Davis Research Division of Warner-Lambert company in the United States. He is an Honourary Fellow and Adjunct Professor at the Hong Kong University of Science and Technology. He has also been appointed as a member of the Chinese People’s Political Consultative Conference of Anhui Province in China in January 2018. He is the founder of the Group and has been responsible for the daily operations and research and development of the Group since 1994. He is the brother of Ms. Lee Siu Fong and Ms. Leelalertsuphakun Wanee.
Simon Miles Ball
Mr. Simon Miles Ball joined the Board on 29 December 2017. He has more than 17 years of business and management experience within the pharmaceutical industry. He is currently the Global Head of Business Development of the Leadiant Biosciences Group (formerly Sigma Tau Group). He also serves as Country General Manager in United Kingdom, Ireland and Nordics in Leadiant Biosciences Limited and he is a member of the board of directors of Leadiant Biosciences Limited in United Kingdom and Exelead Inc. in the United States of America (formerly known as PharmaSource Inc., the manufacturing company within the Leadiant Biosciences Group). Mr. Ball is also a consultant of Qualister S.A., which is a substantial shareholder of the Company. Mr. Ball obtained his degree in physiology from the University of Leeds. Save as the above, he does not have any relationship with any Director, substantial shareholder or controlling shareholder of the Company.
Chan Yau Ching, Bob
Chairman of audit committee & member of remuneration committee, PhD, MBA, BBA, CFA, MHKSI
Dr. Chan Yau Ching, Bob joined the independent Board on 14 January 2002. Dr. Chan has extensive experience in corporate development and financial management of high-growth companies. He had been a finance professor, researcher and consultant. He had also served directorship at various listed and privately held companies in Hong Kong and in the United States. Currently, he is the managing director of KBR Capital Limited, a company engaged in advising clients on management and investment activities in China and Hong Kong. He is the independent nonexecutive director of China High Speed Transmission Equipment Group Co., Ltd. and Daisho Microline Holdings Limited, which are listed companies on the main board of the Stock Exchange of Hong Kong Limited. He is also an independent non-executive director of Hangzhou Huaxing Chuangye Communication Technology Co., Ltd., which is a listed company on the Shenzhen Stock Exchange. He does not have any relationship with any Director, substantial shareholder or controlling shareholder of the Company.
Lam Yat Cheong
Member of audit committee, CPA (Practising), FCCA, BBA
Mr. Lam Yat Cheong joined the independent Board on 1 July 2004. Mr. Lam is a sole proprietor of an audit firm and has over 30 years of auditing and accounting experience. He is a fellow member of the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants. He had also served directorship at various listed companies in Hong Kong. He does not have any relationship with any Director, substantial shareholder or controlling shareholder of the Company.
Tsim Wah Keung, Karl
Chairman of remuneration committee and member of audit committee, PhD, MPhil, BSc
Dr. Tsim Wah Keung, Karl joined the independent Board on 20 September 2004. He currently serves as Chair Professor of Life Science at the Hong Kong University of Science and Technology. He holds a Bachelor of Science degree and a Master degree in Biochemistry from the Chinese University of Hong Kong, and a Doctorate in Molecular Neurobiology from the University of Cambridge. He has published numerous articles in biological sciences and traditional Chinese medicines. He also serves in several local committees in advising the development of traditional Chinese medicine as health food products. He does not have any relationship with any Director, substantial shareholder or controlling shareholder of the Company.